FXR bile acid
Selected indexed studies
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. (Am J Physiol Gastrointest Liver Physiol, 2020) [PMID:31984784]
- Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis. (Int J Mol Sci, 2022) [PMID:35682726]
- Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. (Microbiome, 2023) [PMID:38001551]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage. (2024) pubmed
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. (2020) pubmed
- Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis. (2022) pubmed
- Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. (2018) pubmed
- Bile Acid Metabolism in Liver Pathobiology. (2018) pubmed
- Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. (2013) pubmed
- Bile Acid Physiology. (2017) pubmed
- Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. (2023) pubmed
- Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders. (2022) pubmed
- Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis. (2023) pubmed